Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor

Diabetes

Volumn 57, Issue 1, 2008, Pages 269-275

  Gysemans, Conny ^a   Van Etten, Evelyne ^a   Overbergh, Lutgart ^a   Giulietti, Annapaula ^a   Eelen, Guy ^a   Waer, Mark ^a   Verstuyf, Annemieke ^a   Bouillon, Roger ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPTOTAGMIN I; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC ANALYSIS; INCIDENCE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; ANIMAL; CROSS BREEDING; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE MUTANT; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; FEMALE; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES;

EID: 38449087569     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1095     Document Type: Article

References (23)

1. Beran D, Yudkin JS: Diabetes care in sub-Saharan Africa. Lancet 368:1689-1695, 2006
2. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773, 2006
3. Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 116:2062-2072, 2006
4. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM: Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500-1503, 2001
5. Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallonne B, Overbergh L, Bouillon R, Mathieu C: Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 47:451-462, 2004
6. 3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 417:77-80, 2003
7. 3 prevents insulitis in NOD mice. Diabetes 41:1491-1495, 1992
8. 3. Diabetologia 37:552-558, 1994
9. 3 analogs as immunomodulatory agents. Trends Mol Med 8:174-179, 2002
10. Chang TJ, Lei HH, Yeh JI, Chiu KC, Lee KC, Chen MC, Tai TY, Chuang LM: Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol (Oxf) 52:575-580, 2000
11. Motohashi Y, Yamada S, Yanagawa T, Maruyama T, Suzuki R, Niino M, Fukazawa T, Kasuga A, Hirose H, Matsubara K, Shimada A, Saruta T: Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab 88:3137-3140, 2003
12. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S: Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396, 1997
13. Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD: B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med 184:2049-2053, 1996
14. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, Elmquist JK, Cohen RN, Wondisford FE: An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci USA 98:3998-4003, 2001
15. Skorija K, Cox M, Sisk JM, Dowd DR, Macdonald PN, Thompson CC, Demay MB: Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol 19:855-862, 2005
16. 3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98:6800-6805, 2001
17. 3 to suppress experimental autoimmune encephalomyelitis in mice. Arch Biochem Biophys 408:200-204, 2002
18. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861-7864, 1996
19. Froicu M, Cantorna MT: Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 8:5, 2007
20. Godfrey DI, Kinder SJ, Silvera P, Baxter AG: Flow cytometric study of T cell development in NOD mice reveals a deficiency in TCR-α/β+CD4-CD8- thymocytes. J Autoimmun 10:279-285, 1997
21. + T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 55:2098-2105, 2006
22. Serreze DV, Gedeke JW, Leiter EH: Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 90:9625-9629, 1993
23. Dahlen E, Hedlund G, Dawe K: Low CD86 expression in the non-obese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J Immunol 164:2444-2456, 2000